15 Nov Still No Iluvien
Alimera Sciences suffers set back with Iluvien. In a complete response letter to the company, the FDA did not approve the device for diabetic retinopathy citing concerns over safety....
Alimera Sciences suffers set back with Iluvien. In a complete response letter to the company, the FDA did not approve the device for diabetic retinopathy citing concerns over safety....
Though the FDA upheld its decision no longer approve Avastin for the treatment of breast cancer. The drug is still available for eye patients....
Small study shows long-lasting effects of intravitreal steroids for the treatment of diabetic macular edeam, a common complication of diabetic retinopathy. ...
Dexamethsone steroid device has immediate implications for the treatment of diabetic macular edema....
Standard of care establishes how doctors choose which treatment is most appropriate in a given situation....